Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Vaxart Announces Preclinical Data Showing Its Mucosal Vaccine Technology Stimulates Immune Response Against HPV-Related Tumors, Reduces Tumor Size, And Increases Survival In Animal Model, Indicating Potential For Non-Invasive Treatment Of HPV-Related Cervical Dysplasia

Author: Benzinga Newsdesk | August 28, 2024 08:04am

Posted In: VXRT